SE0000332D0 - New use - Google Patents

New use

Info

Publication number
SE0000332D0
SE0000332D0 SE0000332A SE0000332A SE0000332D0 SE 0000332 D0 SE0000332 D0 SE 0000332D0 SE 0000332 A SE0000332 A SE 0000332A SE 0000332 A SE0000332 A SE 0000332A SE 0000332 D0 SE0000332 D0 SE 0000332D0
Authority
SE
Sweden
Prior art keywords
new use
treatment
rofleponide
ibs
medicament
Prior art date
Application number
SE0000332A
Other languages
English (en)
Swedish (sv)
Inventor
Ralph Brattsand
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0000332A priority Critical patent/SE0000332D0/xx
Publication of SE0000332D0 publication Critical patent/SE0000332D0/xx
Priority to MXPA02007342A priority patent/MXPA02007342A/es
Priority to AU30652/01A priority patent/AU3065201A/en
Priority to BR0107935-2A priority patent/BR0107935A/pt
Priority to JP2001556477A priority patent/JP2003521519A/ja
Priority to RU2002118326/14A priority patent/RU2002118326A/ru
Priority to CZ20022630A priority patent/CZ20022630A3/cs
Priority to CA002396197A priority patent/CA2396197A1/en
Priority to SK1029-2002A priority patent/SK10292002A3/sk
Priority to IL15040401A priority patent/IL150404A0/xx
Priority to PCT/SE2001/000069 priority patent/WO2001056578A1/en
Priority to EEP200200423A priority patent/EE200200423A/xx
Priority to KR1020027009793A priority patent/KR20030004333A/ko
Priority to US10/181,345 priority patent/US20030004214A1/en
Priority to PL01366171A priority patent/PL366171A1/xx
Priority to ZA200205234A priority patent/ZA200205234B/en
Priority to IS6462A priority patent/IS6462A/is
Priority to NO20023463A priority patent/NO20023463D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
SE0000332A 2000-01-31 2000-01-31 New use SE0000332D0 (sv)

Priority Applications (18)

Application Number Priority Date Filing Date Title
SE0000332A SE0000332D0 (sv) 2000-01-31 2000-01-31 New use
PL01366171A PL366171A1 (en) 2000-01-31 2001-01-15 Use of rofleponide in the treatment of irritable bowel syndrome (ibs)
SK1029-2002A SK10292002A3 (sk) 2000-01-31 2001-01-15 Použitie rofleponidu pri liečení syndrómu dráždivého čreva
PCT/SE2001/000069 WO2001056578A1 (en) 2000-01-31 2001-01-15 Use of rofleponide in the treatment of irritable bowel syndrome (ibs)
BR0107935-2A BR0107935A (pt) 2000-01-31 2001-01-15 Uso de rofleponida, seus ésteres e sais, método para tratar um paciente que sofre de sìndrome do intestino irritável, e, formulação farmacêutica para uso no tratamento da sìndrome do intestino irritável
JP2001556477A JP2003521519A (ja) 2000-01-31 2001-01-15 過敏性腸症候群の処置におけるロフレポニドの使用
RU2002118326/14A RU2002118326A (ru) 2000-01-31 2001-01-15 Применение рофлепонида в лечении синдрома раздражения кишечника (СРК)
CZ20022630A CZ20022630A3 (cs) 2000-01-31 2001-01-15 Pouľití rofleponidu pro léčení syndromu dráľdivého střeva
CA002396197A CA2396197A1 (en) 2000-01-31 2001-01-15 Use of rofleponide in the treatment of irritable bowel syndrome (ibs)
MXPA02007342A MXPA02007342A (es) 2000-01-31 2001-01-15 Uso de rofleponida en el tratamiento del sindorme del intestino irritable (sii9.
IL15040401A IL150404A0 (en) 2000-01-31 2001-01-15 Use of rofleponide in the treatment of irritable bowel syndrome (ibs)
AU30652/01A AU3065201A (en) 2000-01-31 2001-01-15 Use of rofleponide in the treatment of irritable bowel syndrome (ibs)
EEP200200423A EE200200423A (et) 2000-01-31 2001-01-15 Rofleponiidi kasutamine ärritunud soole sündroomi(IBS) ravis
KR1020027009793A KR20030004333A (ko) 2000-01-31 2001-01-15 과민성 대장증후군 (ｉｂｓ)의 치료에 대한로플레포나이드의 용도
US10/181,345 US20030004214A1 (en) 2000-01-31 2001-01-15 Use of rofleponide in the treatment of irritable bowel syndrome (ibs)
ZA200205234A ZA200205234B (en) 2000-01-31 2002-06-28 Use of rofleponide in the treatment of irritable bowel syndrome (IBS).
IS6462A IS6462A (is) 2000-01-31 2002-07-09 Notkun á róflepóníði við meðhöndlun á ristilkrampa (IBS)
NO20023463A NO20023463D0 (no) 2000-01-31 2002-07-19 Anvendelse av rofleponid i behandling av irritabelt tarmsyndrom (IBS)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0000332A SE0000332D0 (sv) 2000-01-31 2000-01-31 New use

Publications (1)

Publication Number Publication Date
SE0000332D0 true SE0000332D0 (sv) 2000-01-31

Family

ID=20278315

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0000332A SE0000332D0 (sv) 2000-01-31 2000-01-31 New use

Country Status (18)

Country Link
US (1) US20030004214A1 (cs)
JP (1) JP2003521519A (cs)
KR (1) KR20030004333A (cs)
AU (1) AU3065201A (cs)
BR (1) BR0107935A (cs)
CA (1) CA2396197A1 (cs)
CZ (1) CZ20022630A3 (cs)
EE (1) EE200200423A (cs)
IL (1) IL150404A0 (cs)
IS (1) IS6462A (cs)
MX (1) MXPA02007342A (cs)
NO (1) NO20023463D0 (cs)
PL (1) PL366171A1 (cs)
RU (1) RU2002118326A (cs)
SE (1) SE0000332D0 (cs)
SK (1) SK10292002A3 (cs)
WO (1) WO2001056578A1 (cs)
ZA (1) ZA200205234B (cs)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6730350B2 (ja) * 2018-03-19 2020-07-29 ファナック株式会社 制御装置

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9704833D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New formulation

Also Published As

Publication number Publication date
IL150404A0 (en) 2002-12-01
US20030004214A1 (en) 2003-01-02
ZA200205234B (en) 2003-09-29
CA2396197A1 (en) 2001-08-09
IS6462A (is) 2002-07-09
EE200200423A (et) 2003-12-15
SK10292002A3 (sk) 2002-11-06
JP2003521519A (ja) 2003-07-15
WO2001056578A1 (en) 2001-08-09
MXPA02007342A (es) 2002-12-09
BR0107935A (pt) 2003-01-21
CZ20022630A3 (cs) 2003-01-15
NO20023463L (no) 2002-07-19
NO20023463D0 (no) 2002-07-19
KR20030004333A (ko) 2003-01-14
PL366171A1 (en) 2005-01-24
AU3065201A (en) 2001-08-14
RU2002118326A (ru) 2004-01-10

Similar Documents

Publication Publication Date Title
NO20013469D0 (no) Fremgangsmåter for glukagonsuppresjon
PL371736A1 (en) Method for administering glp-1 molecules
EE200300212A (et) Ravimite kombinatsioonid (näiteks kloorpromasiin ja pentamidiin) neoplastiliste haiguste raviks
IS6994A (is) Arípíprazóllausn til gjafar um munn
NO20062504L (no) Sammensetninger og doseringsformer for forbedret absorpsjon
CY1106602T1 (el) Παραγωγα αδαμαντανιου για τη θεραπεια φλεγμονωδων, ανοσολογικων και καρδιαγγειακων ασθενειων
HRP20041152B1 (en) Pharmaceutical formulations
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
DE50005529D1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
CY1109361T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
SE0101932D0 (sv) Pharmaceutical combinations
HK1068606A1 (en) Novel aminobenzoephenones
CY1107231T1 (el) Υποκατεστημενα παραγωγα 4-αμινοκυκλοεξανολης
HRP20070291T3 (en) Pharmaceutical composition comprising a zinc-hyaluronate complex for the treatment of multiple sclerosis
DK1957037T3 (da) Farmaceutisk præparat til nasal anvendelse af fentanyl
EA200501697A1 (ru) Дозируемая форма, содержащая пантопразол в качестве активного ингредиента
SE0200657D0 (sv) Novel Formulation
EE05241B1 (et) Distamtsiini a-halogenoakrlolderivaadi kasutamine
EA200200853A1 (ru) Применение 2-метилтиазолидин-3,3-дикарбоновой кислоты (2-мтдк) и/или ее физиологически совместимых солей для лечения и/или предупреждения рака
ATE297760T1 (de) Pharmazeutische zusammensetzungen enthaltend terbinafin
SE0000332D0 (sv) New use
DK1273301T3 (da) Farmaceutiske præparater baseret på aktive bestanddele der kan anvendes til ulovlig administration
BG105984A (bg) Използване на озанетант за приготвяне на лекарствени средства полезни за лечение на разстройства на настроението
ATE402719T1 (de) Injiziebare pharmazeutische zusammensetzung enthaltend ethanol zur behandlung von bandscheibenvorfällen
DK1420789T3 (da) Anvendelse af aktivstoffer med my-opioid-receptoragonistisk virkning og opioid-receptorantagonistisk virkning som kombinationslægemidler til cancerbehandling